VAERS reports by lot

Merck HPV lot 0216Y: VAERS reports

24 VAERS reports list lot 0216Y as a Merck HPV vaccine, received between 2009-10-01 and 2013-04-01. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
24
Reports
38%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2227%
Neurological1822%
Cardiac / Cardiovascular79%
Allergic / Anaphylactic79%
Gastrointestinal67%
Injection-site / Local reaction67%
Musculoskeletal56%
Dermatological (non-injection-site)34%
Reproductive / Menstrual34%
Respiratory22%
Psychiatric / Neuropsychiatric22%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California3
Massachusetts2
North Carolina2
Pennsylvania2
Oregon1
New York1
Kansas1
Wisconsin1
Maine1
Texas1
Maryland1
New Jersey1

Reports by month received

2009-104
2009-111
2010-011
2010-023
2010-032
2010-052
2010-097
2011-051
2011-082
2013-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.